Case Study

Saving Development Time And Economizing Distribution With A Single-Vendor Approach

By Doug Ahrens, Senior Integrated Offering Manager, Thermo Fisher Scientific, and Mike Pearson, Staff Program Manager, Thermo Fisher Scientific

iStock-1278931804-project-management-computer

When preparing to scale up for clinical production, many companies opt to work with multiple CDMOs to ensure supply chain stability. However, managing multiple vendors can take time and focus away from the primary objective – getting the drug ready for trials. This can make it challenging to find a CDMO that meets all of a client’s needs.

In 2018, Kaleido Biosciences took a chance on a single-vendor approach using Thermo Fisher Scientific’s Quick to Care™ program. Kaleido uses differentiated chemistry to produce targeted microbiome treatments. Its complex process and short timeline made for a challenging project, but Thermo Fisher Scientific’s resources ensured a seamless tech transfer and brought the drug to trial participants around the globe on time as promised.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: